Patient Information

Yes. Please complete our referral form.

Utilizing the world’s most advanced scanning technology, BAMF Health can conduct PET scans for prostate cancer, neuroendocrine cancer, breast cancer, lung cancer, colon/rectal cancer, lymphoma, melanoma, multiple myeloma, brain cancer and ovarian cancers. Imaging on the BAMF Health platform allows for better staging and treatment planning and can help avoid unnecessary procedures.

Yes. Please complete our referral form.

After a detailed evaluation of your health history, BAMF Health’s physicians, who specialize in theranostics, will guide you through the right theranostic therapy if you are determined to be a candidate.

Yes. Please complete our referral form.

After a detailed evaluation of your health history, BAMF Health’s physicians, who specialize in theranostics, will guide you through the right theranostic therapy if you are determined to be a candidate.

Yes. Please complete our referral form.

If your family history or genomic profile reflects a predisposition to cancer, BAMF Health can offer the most advanced monitoring, imaging, and comprehensive road map to understanding disease.

Imaging on the BAMF Health platform allows for better staging and treatment planning while avoiding unnecessary procedures.

Yes. We offer NeuraCeq® amyloid scanning to help determine if cognitive impairment is due to Alzheimer’s disease or other causes of Dementia.

Your physician can order this scan using this form

For more information, learn more about NeuraCeq®

Yes. Please complete our referral form.

In the near future, BAMF Health will begin addressing and assisting patients with heart-related diseases using novel molecular imaging technology.

Theranostic treatments for both prostate and neuroendocrine cancers have been approved by the FDA.

Theranostic treatments for other cancers are currently in clinical trials and are under priority review by the FDA.

We will help you navigate insurance coverage and financial assistance ahead of scheduling care.

Most treatments and scans are covered by insurance.

Please view our current clinical trials.

After a detailed evaluation of your health history, our clinical experts will determine if you are a candidate for a current or upcoming clinical trial.

Please note that BAMF Health will rapidly begin participating in a wide variety of Clinical Trials throughout 2023. Please check back for updates soon.

Theranostics is an emerging field in medicine with proven results, combining the power of molecular imaging and molecular targeted radiation therapy to accurately diagnose and treat patients.

After locating and identifying the disease through molecular imaging, a simple IV injection delivers targeted treatment directly to where it is needed, minimizing damage to healthy tissue.